Publications

Publications and presentations featuring GBA and LLRK2 iCell DopaNeurons should reference the Parkinson's Progression Markers Initiative (PPMI) and the Golub Capital iPSC PPMI Sub-study (www.ppmi-info.org) as the original iPS cell line(s) source for the differentiated cells used in these experiments. Publications should acknowledge that the Parkinson's Progression Markers Initiative (PPMI) is a public-private partnership funded by The Michael J. Fox Foundation for Parkinson’s Research and other funding partners. Publications using these cells should be made available without charge to the research community through the PPMI website, when not prohibited by publication copyright terms and conditions. For assistance in uploading to the PPMI website, please contact: https:/www.ppmi-info.org/contact-us/. ()

Hesham Basma, Swetha Tatineni, Kajari Dhar, Fang Qiu, Stephen Rennard, Brian D. Lowes (2020) BMC Cardiovasc Disord. 20: 357. (2020)

Christopher A. Werley, Stefano Boccardo, Alessandra Rigamonti, Emil M. Hansson & Adam E. Cohen (2020) Nature Comm. 11: 3881. (2020)

Takayama Y, Kushige H, Akagi Y, Suzuki Y, Kumagai Y & Kida YS (2020) Scientific Reports 10: 9464 (2020)

Yun SH, Shin HH, Ju ES, Lee YJ, Lim BK & Jeon ES (2020) Int. J. Mol. Sci. 21: 3041. (2020)

Richards DJ, Li Y, Kerr CM, Yao J, Beeson GC, Coyle RC, Chen X, Jia J, Damon B, Wilson R, Starr Hazard E, Hardiman G, Menick DR, Beeson CC, Yao H, Ye T, Mei Y (2020) Nat Biomed Eng. 4(4):446-462. (2020)

A Tukker, L Bouwman, R van Kleef, H Hendriks, J Legler, R Westerink. (2020) Sci. Rep. 10, 5311 (2020)

Liu L, Koo Y, Russell T, Gay E, Li Y, Yun Y PLoS One. (2020) 15(3): e0230335. (2020)

Palmer JA, Smith AM, Gryshkova V, Donley ELR, Valentin JP, Burrier RE (2020) Toxicol Sci.174(2):218-240. (2020)